The purpose of this work was to develop rapidly disintegrating tablet (RDT) of artemether-lumefantrine fixed dose combinations (FDC). RDTs disintegrate either rapidly in water, to form a stabilized suspension, or disperse instantaneously in the mouth to be swallowed without the aid of water. Granules containing artemether, lumefantrine, camphor, crospovidone (CPVP), and Avicel® PH 101 were prepared by wet granulation technique and the granules were air dried overnight. Tablets were first prepared and later exposed to vacuum to sublime the camphor. The tablets were evaluated for percentage friability, wetting time, disintegration time and other characteristics. A 22 full factorial design was used to investigate the combined influence of 2 fo...
Metoclopramide HCl (MTB) is a potent antiemetic drug used for the treatment of nausea and vomiting. ...
Orally disintegrating tablet formulations that involve active pharmaceutical ingredients in combinat...
The aim of this study was to design and evaluate the mouth dissolving dosage form of domperidone dru...
Artemether and lumefantrine are anitmalarial drugs used in the management of malaria. The objective ...
ABSTRACT: The purpose of this research was to develop orodispersible tablets of atenolol. Tablets co...
The ease of administration and increased patient compliance are critical factors in the design of or...
The aim of this study was to study the effect of disintegrate type on the characteristics of fast ...
Oral disintegrating tablets are defined as the tablets that disperse or disintegrates in less than o...
Orally disintegrating tablets are a vital tool in keeping our children and elderly population health...
Purpose: To develop and validate a dissolution test method for dissolution release of artemether and...
Purpose: To develop and validate a dissolution test method for dissolution release of artemether and...
Introduction: Rizatriptan benzoate is a potent and selective 5-HT1B/1D receptor agonist and is effec...
The aim of this work is to prepare fast dissolving tablets of Diltiazem Hydrochloride to improve pat...
A new pharmaceutical product suitable to act as a negative contrast agent for Computerized Scan (CT-...
Difficulty in swallowing (dysphagia) is common among all age groups, especially in elderly and pedia...
Metoclopramide HCl (MTB) is a potent antiemetic drug used for the treatment of nausea and vomiting. ...
Orally disintegrating tablet formulations that involve active pharmaceutical ingredients in combinat...
The aim of this study was to design and evaluate the mouth dissolving dosage form of domperidone dru...
Artemether and lumefantrine are anitmalarial drugs used in the management of malaria. The objective ...
ABSTRACT: The purpose of this research was to develop orodispersible tablets of atenolol. Tablets co...
The ease of administration and increased patient compliance are critical factors in the design of or...
The aim of this study was to study the effect of disintegrate type on the characteristics of fast ...
Oral disintegrating tablets are defined as the tablets that disperse or disintegrates in less than o...
Orally disintegrating tablets are a vital tool in keeping our children and elderly population health...
Purpose: To develop and validate a dissolution test method for dissolution release of artemether and...
Purpose: To develop and validate a dissolution test method for dissolution release of artemether and...
Introduction: Rizatriptan benzoate is a potent and selective 5-HT1B/1D receptor agonist and is effec...
The aim of this work is to prepare fast dissolving tablets of Diltiazem Hydrochloride to improve pat...
A new pharmaceutical product suitable to act as a negative contrast agent for Computerized Scan (CT-...
Difficulty in swallowing (dysphagia) is common among all age groups, especially in elderly and pedia...
Metoclopramide HCl (MTB) is a potent antiemetic drug used for the treatment of nausea and vomiting. ...
Orally disintegrating tablet formulations that involve active pharmaceutical ingredients in combinat...
The aim of this study was to design and evaluate the mouth dissolving dosage form of domperidone dru...